FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/08/035334 [Registered on: 02/08/2021] Trial Registered Prospectively
Last Modified On: 30/07/2021
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Clinical evaluation of Rajapravartani Vati in Painful Menstruation 
Scientific Title of Study   A prospective community based study for the evaluation of Rajapravartani Vati in the Management of Primary Dysmenorrhoea 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  CHRIS ANTONY 
Designation  Research Officer Ayurveda 
Affiliation  Regional Ayurveda Research Institute CCRAS Mandi Himachal Pradesh 
Address  Room No 4 Ayurveda Department Kaumarabhritya Division Regional Ayurveda Research Institute Jaral Colony Pandoh Mandi District Himachal Pradesh

Mandi
HIMACHAL PRADESH
175124
India 
Phone  7807773464  
Fax    
Email  chrisantony1@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  CHRIS ANTONY 
Designation  Research Officer Ayurveda 
Affiliation  Regional Ayurveda Research Institute CCRAS Mandi Himachal Pradesh 
Address  Room No 4 Ayurveda Department Kaumarabhritya Division Regional Ayurveda Research Institute Jaral Colony Pandoh Mandi District Himachal Pradesh

Mandi
HIMACHAL PRADESH
175124
India 
Phone  7807773464  
Fax    
Email  chrisantony1@gmail.com  
 
Details of Contact Person
Public Query
 
Name  CHRIS ANTONY 
Designation  Research Officer Ayurveda 
Affiliation  Regional Ayurveda Research Institute CCRAS Mandi Himachal Pradesh 
Address  Room No 4 Ayurveda Department Kaumarabhritya Division Regional Ayurveda Research Institute Jaral Colony Pandoh Mandi District Himachal Pradesh

Mandi
HIMACHAL PRADESH
175124
India 
Phone  7807773464  
Fax    
Email  chrisantony1@gmail.com  
 
Source of Monetary or Material Support  
Central Council for Research in Ayurvedic Sciences CCRAS New Delhi 
 
Primary Sponsor  
Name  Central Council for Research in Ayurvedic Sciences CCRAS 
Address  Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan 61-65 Institutional Area Opposite D Block Janakpuri New Delhi 110058 
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 10  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Susmita P Otta  Central Ayurveda Research Institute Bhubaneswar  Room No 02 Ayurveda Department Prasuti evam Streeroga Division Central Ayurveda Research Institute Bhubaneswar Bharatpur Bhubaneswar
Khordha
ORISSA 
8089375057

drsusmitaro@gmail.com 
Dr Jeuti Rani Das  Central Ayurveda Research Institute Guwahati  Room No 209 Ayurveda Department Rogavijnana Vikriti Vijana Division Central Ayurveda Research Institute Barsojai Beltola Guwahati Kamrup District Assam PIN 781028
Kamrup
ASSAM 
9509192744

djeutirani@yahoo.in 
Dr Rinku Tomar  Central Ayurveda Research Institute Patiala  Room No 211 Ayurveda Department Prasooti evam Striroga Division Central Ayurveda Research Institute Patiala Moti Bagh Road Patiala Punjab
Patiala
PUNJAB 
9888685874

drrinkutomer2008@gmail.com 
Dr Swati Sharma  M S Regional Ayurveda Research Institute Jaipur  Room No 01 Ayurveda Department Kaumarabhritya Division M S Regional Ayurveda Research Institute Jaipur Indira Colony Banipark Jhotwara Road Jaipur
Jaipur
RAJASTHAN 
7318324555

drswatisharma2010@gmail.com 
Dr Jaiprakash Ram  Regional Ayurveda Research Institute Ahmedabad  Room No 02 Ayurveda Department Kayachikitsa Division Regional Ayurveda Research Institute Asarwa Ahmedabad Gujarat PIN 380004
Ahmadabad
GUJARAT 
7791834211

jpram236@gmail.com 
Dr Harit Kumari  Regional Ayurveda Research Institute Lucknow  Room No 312 Ayurveda Department Shalyatantra Division Regional Ayurveda Research Institute INS 106 Sector 25 Indira Nagar Lucknow UP PIN 226016
Lucknow
UTTAR PRADESH 
9837078947

drharit79@gmail.com 
Dr Chris Antony  Regional Ayurveda Research Institute Mandi  Room No 4 Ayurveda Department Kaumarabhritya Division Regional Ayurveda Research Institute Jaral Colony Pandoh Mandi District Himachal Pradesh
Mandi
HIMACHAL PRADESH 
7807773464

chrisantony1@gmail.com 
Dr Prashant R Shinde  Regional Ayurveda Research Institute Nagpur  Room No 02 Ayurveda Department Prasutitantra evam Striroga Division Regional Ayurveda Research Institute Nagpur Near Gharkul Parisar N I T Complex Nandavan Nagpur
Nagpur
MAHARASHTRA 
9623011214

drshindeprashant07@gmail.com 
Dr Kuldeep  Regional Ayurveda Research Institute Patna  Room No 09 Ayurveda Department Panchakarma Division Regional Ayurveda Research Institute Patna Agam Kuan Patna
Patna
BIHAR 
8954354560

kuldeepccras@gmail.com 
Dr Meghna P P  Regional Ayurveda Research Institute Thiruvananthapuram  Room No 21 First floor Ayurveda Department Prasutitantra Streeroga Division Regional Ayurveda Research Institute Thiruvananthapuram Poojappura Thiruvananthapuram
Thiruvananthapuram
KERALA 
9074126423

drmeghnapp@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 10  
Name of Committee  Approval Status 
Ethics Committee RARI Nagpur  Approved 
Institutional Ethics Committee Central Ayurveda Research Institute Bhubaneswar  Approved 
Institutional Ethics Committee Central Ayurveda Research Institute Guwahati Assam  Approved 
Institutional Ethics Committee Central Ayurveda Research Institute Patiala  Approved 
Institutional Ethics Committee for Biomedical Research RARI Thiruvananthapuram  Approved 
Institutional Ethics Committee M S Regional Ayurveda Research Institute Jaipur  Approved 
Institutional Ethics Committee Regional Ayurveda Research Institute Ahmedabad Gujarat  Approved 
Institutional Ethics Committee Regional Ayurveda Research Institute Lucknow Uttar Pradesh  Approved 
Institutional Ethics Committee Regional Ayurveda Research Institute Mandi Himachal Pradesh  Approved 
Institutional Ethics Committee Regional Ayurveda Research Institute Patna  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N944||Primary dysmenorrhea. Ayurveda Condition: UDAVARTINI,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Rajapravartani Vati, Reference: AFI Part 1 12 25, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: Lukewarm water), Additional Information: Drug will be given for 3 menstrual cycles and follow up without drug will be done for 1 menstrual cycle
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  25.00 Year(s)
Gender  Female 
Details  i.Young women of age 18 -25 years of scheduled Caste community
ii.Self-reported history consistent with primary dysmenorrheal of moderate to severe nature (Mild: doesn’t interfere in normal activities, Moderate: slightly interferes in daily routines but can be managed by painkillers, Severe: markedly prevents daily life activities) with a self-reported menstrual cycle of averaging 21-35 days.
iii.Willing and able to participate in the study (Written informed consent or assent).
 
 
ExclusionCriteria 
Details  i.Irregular Cycles.
ii.Cases of secondary Dysmenorrhea
iii.Pain abdomen associated with excessive bleeding per vagina.
iv.Presence of persistent pelvic pain throughout the menstrual cycle.
v.Known case / diagnosis /h/o of leiomyoma of uterus, ovarian cyst, endometriosis.
vi.Associated with clinically diagnosed pelvic inflammatory disease (PID),
vii.Associated with any pre-diagnosed or clinically diagnosed systemic disorders likely to influence menstrual cycle.
viii.Patients with Hb ≤ 7 gm %
ix.History of malignancy of pelvic organs.
x.Diagnosed cases Hypo/hyperthyroidism .
xi.Woman using IUD / Oral Contraceptive Pills (OCP)
xii.Patient co morbid with systemic diseases like diabetes mellitus, hypertension, cardiac/ Renal/ Pulmonary/ Hepatic disorders.
xiii.Women who are planning to conceive in the next 6 months.
xiv.Participation in other concomitant therapy for acute or chronic pain.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
i.Change in Visual Analog Scale (VAS) for pain.  At baseline, after 1 month, after 2 months, after 3 months and after 4 months. 
 
Secondary Outcome  
Outcome  TimePoints 
i.Changes in total WaLLID score.
ii.Change in Hb status of the subject from the baseline to the end of trial -12 weeks.
iii.Decrease in the use of Analgesic medication (dosage & frequency of medication used)
 
[Time Frame: Assessed via questionnaire after every menstrual cycle for four cycles] 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   04/08/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The study is a prospective community based study for the evaluation of clinical effects of Rajapravartani vati in the management of Primary Dysmenorrhoea. It is a single arm trial with a sample size of 50 at each partcipating center (total 10 CCRAS centers). The outcome measures are VAS Score and WaLLIDD score.  
Close